Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.91 USD
+0.09 (4.95%)
Updated May 31, 2024 03:59 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Cresco Labs Inc. [CRLBF]
Reports for Purchase
Showing records 121 - 128 ( 128 total )
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: CAOA Federal Reform Update and Alcohol Tier Model in Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: NJ and NY Conversion Catalyst Fueling M&A
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Accretive? TBD. Irony as Major Acquisition Likely to Cause ?Divestitures? to Become CL?s Buzz Word for the NTM. Q421 Underwhelms Muted Expectations
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Cresco Labs Inc.
Industry: Medical - Products
4Q21 Soft, Transformative Acquisition of Columbia Care, Lower PT to $12
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Unclassified
4Q21 MSO Preview: Expect Flat Results & Tempered ''22 Guidance Outlooks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S